WIRE, CUTR and USEG Are Among Premarket Gainers
Seeking AlphaApr 15 08:41 ET
Intercure Ltd. Submits SEC Compliance Report
TipRanksApr 1 09:40 ET
Express News | InterCure Announces Preliminary 2023 Revenue Of NIS 351 Million And EBITDA Of Over NIS 50 Million
Moomoo 24/7Apr 1 09:11 ET
Press Release: InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 Million and EBITDA of Over NIS 50 Million
InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million -- Revenues for H2 2023 were affected by damages caused by the terrorist attack o
Dow JonesApr 1 09:09 ET
InterCure Congratulates Germany on Cannabis Reform, Expanding Its Global Footprint
InterCure provides an update following recent Cannabis Reform in Germany Expects to launch its first products in Germany in the coming months The Company continues to closely watch developments surrounding
BusinesswireMar 22 11:58 ET
InterCure Advances Restoration of Israeli Site Amid Conflict
InvestingFeb 13 18:44 ET
InterCure Restoring Facility Near Israel-Gaza Border
By Denny Jacob InterCure, which does business as Canndoc, has begun the process of restoring a facility near the Israel-Gaza border and that they are advancing according to its plans. The medical ca
WSJFeb 13 17:12 ET
InterCure Provides an Update Regarding Nir Oz Facility
NEW YORK, and HERZLIYA, Israel, Feb. 13, 2024 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ:INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), the leading medical cannabis company in Israel
GlobeNewswireFeb 13 16:46 ET
InterCure to Buy Isreal-based Leon Cannabis Pharmacy Chain
Seeking AlphaJan 31 10:46 ET
InterCure Will Issue 1,755,000 to 1,845,000 Shrs of the Co to the Sellers, Depending on the Shr Price of the Co at the Time of Completion >INCR
InterCure Will Issue 1,755,000 to 1,845,000 Shrs of the Co to the Sellers, Depending on the Shr Price of the Co at the Time of Completion >INCR
Dow JonesJan 31 09:29 ET
Press Release: InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain
InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain NEW YORK, and HERZLIYA, Israel, Jan. 31, 2024 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc)
Dow JonesJan 31 09:27 ET
Express News | InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain; At Closing, InterCure Will Cause Between 1,755,000 To 1,845,000 Shares Of The Company To Be Issued To The Sellers, Depending On The Share Price Of The Company At The Time Of Com
Moomoo 24/7Jan 31 09:23 ET
WKEY, INCR and ZJYL Are Among Pre Market Gainers
Seeking AlphaJan 10 08:49 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: 60 Degrees Pharmaceuticals, Inc. (SXTP), Arcturus Therapeutics (ARCT) and Intercure (INCR)
TipRanksNov 15, 2023 10:04 ET
Court Rules in InterCure's Favor in Cannolam Arbitration Process
Seeking AlphaOct 31, 2023 17:29 ET
Express News | InterCure Wins Cannolam Arbitration Proceeding; InterCure Holds 100% Of The Shares In Cannolam; Amount Owed Will Be Determined And Paid As Part Of A Full Separation Process
Moomoo 24/7Oct 31, 2023 16:54 ET
InterCure Unable to Assess Damage to Southern Israel Site
By Ben Glickman InterCure, which does business as Canndoc, said it is unable to assess the damage to its facility near the Israel-Gaza border. The medical cannabis company said it had "high certaint
Dow JonesOct 17, 2023 17:23 ET
InterCure Says One of Its Sites Designated as Closed Military Area by Israeli Authorities
Seeking AlphaOct 17, 2023 17:17 ET
InterCure Provides an Update Regarding the Security Situation in Israel
NEW YORK, and HERZLIYA, Israel, Oct. 17, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ:INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), the leading medical cannabis company in Israel
GlobeNewswireOct 17, 2023 17:04 ET
Nano-X, InMode, Teva Among Notable Israel-based Healthcare Decliners
Seeking AlphaOct 9, 2023 13:00 ET
No Data
No Data